MRNA - Moderna, Inc. Common Stock

MRNA

$135.05 0.56 (-0.41%) Last updated: Sep 10, 2026 19:02

52-Week Range

$135.05

$22.28 $135.05 $176.66

Fundamentals Overview

Moderna, Inc. Common Stock is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/B 4.11 P/S 24.47

Risk (Beta)

1.22 — higher vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 40% confidence Risk: High Volatility — Beta 1.22. Consider smaller position size due to higher beta.

Pressures (Sell):

P/S 24.47 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$54.14B

P/E (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$22.28 - $176.66

Volume vs Avg

N/A

Beta

1.22

About

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Sector: stocks

Headquarters:

Website: www.modernatx.com

Beta: 1.22 (More volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	N/A
PEG (TTM)	N/A
P/B (TTM)	4.11
P/S (TTM)	24.47
Profitability
ROE (TTM)	-39.2%
ROA (TTM)	-26.86%
Revenue growth (YoY)	N/A
Net margin (TTM)	-141.43%
Gross margin (TTM)	36.4%
Operating margin (TTM)	-149.01%
Debt to equity (TTM)	0.09

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for MRNA.

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.